Association between health insurance status and malignant glioma.
glioma
insurance status
mobility
socioeconomic status
Journal
Neuro-oncology practice
ISSN: 2054-2577
Titre abrégé: Neurooncol Pract
Pays: England
ID NLM: 101640528
Informations de publication
Date de publication:
Oct 2020
Oct 2020
Historique:
entrez:
5
10
2020
pubmed:
6
10
2020
medline:
6
10
2020
Statut:
epublish
Résumé
Prior studies have suggested an association between patient socioeconomic status and brain tumors. In the present study we attempt to indirectly validate the findings, using health insurance status as a proxy for socioeconomic status. There are 2 types of health insurance in Germany: statutory and private. Owing to regulations, low- and middle-income residents are typically statutory insured, whereas high-income residents have the option of choosing a private insurance. We compared the frequencies of privately insured patients suffering from malignant neoplasms of the brain with the corresponding frequencies among other neurosurgical patients at our hospital and among the German population. To correct for age, sex, and distance from the hospital, we included these variables as predictors in logistic and binomial regression. A significant association (odds ratio [OR] = 1.59, CI = 1.45-1.74, Previous studies have found that people with a higher income, level of education, or socioeconomic status are more likely to suffer from malignant brain tumors. Our findings are in line with these studies. Although the reason behind the association remains unclear, the probability that our results are due to some random effect in the data is extremely low.
Sections du résumé
BACKGROUND
BACKGROUND
Prior studies have suggested an association between patient socioeconomic status and brain tumors. In the present study we attempt to indirectly validate the findings, using health insurance status as a proxy for socioeconomic status.
METHODS
METHODS
There are 2 types of health insurance in Germany: statutory and private. Owing to regulations, low- and middle-income residents are typically statutory insured, whereas high-income residents have the option of choosing a private insurance. We compared the frequencies of privately insured patients suffering from malignant neoplasms of the brain with the corresponding frequencies among other neurosurgical patients at our hospital and among the German population. To correct for age, sex, and distance from the hospital, we included these variables as predictors in logistic and binomial regression.
RESULTS
RESULTS
A significant association (odds ratio [OR] = 1.59, CI = 1.45-1.74,
CONCLUSION
CONCLUSIONS
Previous studies have found that people with a higher income, level of education, or socioeconomic status are more likely to suffer from malignant brain tumors. Our findings are in line with these studies. Although the reason behind the association remains unclear, the probability that our results are due to some random effect in the data is extremely low.
Identifiants
pubmed: 33014394
doi: 10.1093/nop/npaa030
pii: npaa030
pmc: PMC7516122
doi:
Types de publication
Journal Article
Langues
eng
Pagination
531-540Informations de copyright
© The Author(s) 2020. Published by Oxford University Press on behalf of the Society for Neuro-Oncology and the European Association of Neuro-Oncology. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.
Références
J Neurooncol. 2017 Feb;131(3):525-546
pubmed: 27853959
Neuroepidemiology. 2010;35(4):281-90
pubmed: 20948235
Cancer Causes Control. 2015 Feb;26(2):179-185
pubmed: 25421378
Handb Clin Neurol. 2012;105:747-55
pubmed: 22230531
J Neurosci. 2000 Aug 1;20(15):5587-93
pubmed: 10908595
Int J Behav Nutr Phys Act. 2013 Dec 07;10:135
pubmed: 24313992
J Sci Med Sport. 2015 Nov;18(6):684-90
pubmed: 25308630
Res Q Exerc Sport. 2013 Jun;84(2):157-66
pubmed: 23930541
J Epidemiol Community Health. 2010 Aug;64(8):736-43
pubmed: 20670977
Curr Opin Oncol. 2013 Nov;25(6):682-8
pubmed: 24097102
Cancer. 2019 Oct 1;125(19):3390-3400
pubmed: 31206646
Am J Epidemiol. 2010 Nov 15;172(10):1099-107
pubmed: 20858744
Int J Epidemiol. 2003 Apr;32(2):225-33
pubmed: 12714541
Neuro Oncol. 2012 Nov;14 Suppl 5:v1-49
pubmed: 23095881
Cancer Res. 2002 Jun 15;62(12):3347-50
pubmed: 12067971
Med Hypotheses. 2012 May;78(5):657-8
pubmed: 22385772
Crit Rev Oncol Hematol. 2017 Jan;109:51-62
pubmed: 28010898
Neuro Oncol. 2012 Mar;14(3):246-55
pubmed: 22319219
Neuro Oncol. 2018 Oct 1;20(suppl_4):iv1-iv86
pubmed: 30445539
JAMA. 2013 Nov 6;310(17):1842-50
pubmed: 24193082
J Neurooncol. 2007 May;82(3):229-37
pubmed: 17151932
J Neurol Neurosurg Psychiatry. 2004 Jun;75 Suppl 2:ii12-7
pubmed: 15146034
Neuro Oncol. 2010 Dec;12(12):1291-9
pubmed: 21068153
J Epidemiol Community Health. 2016 Dec;70(12):1222-1228
pubmed: 27325866
N Engl J Med. 2005 Mar 10;352(10):987-96
pubmed: 15758009
Annu Rev Sociol. 2010 Aug;36:349-370
pubmed: 21909182